- Coronary Intervention
- Peripheral Intervention
- Vessel Closure
- Carotid Intervention
- Humanitarian Use Device
VOYAGER RX Coronary Dilatation Catheter
Indications & Important Safety Information ›› IFU (Full Version) ››
The evolution of deliverability.
The VOYAGER RX Dilatation Catheter provides the foundation for successful treatments. It combines a low profile, tapered tip design with a low profile shaft, flexible markers and short taper balloon technology to cross tight and tortuous anatomy* with confidence.
*Treatment of moderately or heavily calcified lesions is considered to be moderate risk (Warning Section - IFU).
![]() |
Superb Cross Tapered Tip Design*
|
![]() |
More Options — Low Profile Shaft Design*
|
|
Flexibility with Visibility — Proprietary Tungsten Marker*
|
|
![]() |
Precise Dilatation — Proven Balloon Performance*
|
*Tests performed by and data on file at Abbott Vascular
+Treatment of moderately or heavily calcified lesions is considered to be moderate risk (Warning Section - IFU)
1As compared to CROSSAIL Coronary Dilatation Catheter

AP2932924 Rev.A
Indications and Important Safety Information
VOYAGER RX Coronary Dilatation Catheter
INDICATIONS
The VOYAGER RX Coronary Dilatation Catheter is indicated for:
a) balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion.
b) balloon dilatation of a coronary artery occlusion for the purpose of restoring coronary flow in patients with ST-segment elevation myocardial infarction.
c) balloon dilatation of a stent after implantation.
CONTRAINDICATIONS
The VOYAGER RX Coronary Dilatation Catheter is not intended to be used:
- in an unprotected left main coronary artery;
- to treat coronary artery spasm in the absence of a significant stenosis.
WARNINGS
This device is intended for single-use only; do not reuse. Do not resterilize, as this can compromise device performance and increase the risk of cross contamination due to inappropriate reprocessing.
PTCA (percutaneous transluminal coronary angioplasty) should only be performed at hospitals where emergency coronary artery bypass graft surgery can be quickly performed in the event of a potentially injurious or life-threatening complication.
PTCA in patients who are not acceptable candidates for coronary artery bypass graft surgery requires careful consideration, including possible hemodynamic support during PTCA, as treatment of this patient population carries special risk.
Use only the recommended balloon inflation medium. Never use air or any gaseous medium to inflate the balloon.
Balloon pressure should not exceed the rated burst pressure (RBP). The RBP is based on results of in vitro testing. At least 99.9% of the balloons (with a 95% confidence) will not burst at or below their RBP. To prevent over-pressurization, use a pressure-monitoring device.
To reduce the potential for vessel damage, the inflated diameter of the balloon should approximate the diameter of the vessel just proximal and distal to the stenosis.
When the catheter is exposed to the vascular system, it should be manipulated while under high quality fluoroscopic observation. Do not advance or retract the catheter unless the balloon is fully deflated under vacuum and no resistance is felt. If there is resistance, determine the cause before proceeding. Continuing to advance or retract the catheter while under resistance may result in damage to the vessels and / or damage / separation of the catheter.
Do not use, or attempt to straighten, a catheter if the shaft has become bent or kinked; this may result in the shaft breaking. Instead, prepare a new catheter.
Treatment of moderately or heavily calcified lesions is considered to be moderate risk, with an expected success rate of 60 - 85% and increases the risk of acute closure, vessel trauma, balloon burst, balloon entrapment and associated complications. If resistance is felt, determine the cause before proceeding. Continuing to advance or retract the catheter while under resistance may result in damage to the vessels and / or damage / separation of the catheter.
In the event of catheter damage / separation, recovery of any portion should be performed based on physician determination of individual patient condition and appropriate retrieval protocol.
The VOYAGER OTW Coronary Dilatation Catheter was bench tested with the Guidant MULTI-LINK: PIXEL, PENTA, and ZETA Coronary Stent Systems. The test data is also applicable to the VOYAGER RX. All stents should be deployed in accordance with the manufacturer's indications and instructions for use.
PRECAUTIONS
Note the "Use By" date specified on the package.
Inspect all product prior to use. Do not use if the package is open or damaged.
Prior to angioplasty, the dilatation catheter should be examined to verify functionality and ensure that its size is suitable for the specific procedure for which it is to be used.
During the procedure, provide appropriate anti-coagulant and coronary vasodilator therapy to the patient as needed. Anti-coagulant therapy should be continued for a period of time as determined by the physician after the procedure.
If the surface of the dilatation catheter becomes dry, wetting with heparinized normal saline will reactivate the coating.
Do not reinsert the dilatation catheter into the coil dispenser after procedural use.
This device should be used only by physicians experienced in angiography and percutaneous transluminal coronary angioplasty (PTCA) and / or percutaneous transluminal angioplasty (PTA).
ADVERSE EVENTS
Possible adverse effects include, but are not limited to, the following:
- Acute myocardial infarction
- Arrhythmias, including ventricular fibrillation
- Arteriovenous fistula
- Coronary artery spasm
- Coronary vessel dissection, perforation, rupture or injury
- Death
- Drug reactions, allergic reaction to contrast medium
- Embolism
- Hemorrhage or hematoma
- Hypo / hypertension
- Infection
- Restenosis of the dilated vessel
- Total occlusion of the coronary artery or bypass graft
- Unstable angina





